|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07H 13/04 | |
| C07H 13/08 | |||
| C07H 15/26 | |||
| A61K 31/7042 | |||
| A61K 31/7008 | |||
| A61P 29/00 |
| (11) | Number of the document | 3166956 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15734170.2 |
| Date of filing the European patent application | 2015-07-06 | |
| (97) | Date of publication of the European application | 2017-05-17 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/065313 |
| Date | 2015-07-06 |
| (87) | Number | WO 2016/005311 |
| Date | 2016-01-14 |
| (30) | Number | Date | Country code |
| 14176421 | 2014-07-09 | EP | |
| 14177599 | 2014-07-18 | EP |
| (72) |
LEFFLER, Hakon, SE
NILSSON, Ulf, SE
ZETTERBERG, Fredrik, SE
PETERSON, Kristoffer, SE
|
| (73) |
Galecto Biotech AB,
Cobis Ole Maal es Vej 3, 2200 Copenhagen,
DK
|
| (54) | NOVEL HYBRID GALACTOSIDE INHIBITOR OF GALECTINS |
| NOVEL HYBRID GALACTOSIDE INHIBITOR OF GALECTINS |